Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-069890

Options or other derivatives

  • Director acquired 46,706 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
JOYCE MARTIN JOSEPH Director 2024-06-04 Grant or award · Stock Option (Right to Buy) +40,282 40,282 D
JOYCE MARTIN JOSEPH Director 2024-06-04 Grant or award · Stock Option (Right to Buy) +1,215 1,215 D
JOYCE MARTIN JOSEPH Director 2024-06-04 Grant or award · Stock Option (Right to Buy) +5,209 5,209 D
Loading xslF345X05/ownership.xml…